Phase I/II clinical trial of COVID-2019 vaccine - Biological E. Limited and Adjuvanted-Hepatitis-B-vaccine-(Recombinant)-Dynavax
Latest Information Update: 30 Apr 2021
At a glance
- Drugs Adjuvanted Hepatitis-B vaccine (Recombinant)-Dynavax (Primary) ; COVID-2019 vaccine-Biological E. Limited (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
- 24 Apr 2021 Results published in the Biological E. Limited media release.
- 24 Apr 2021 Status changed from recruiting to completed, according to a Biological E. Limited media release.
- 02 Dec 2020 New trial record